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Abstract
In recent years, there has been a greater concern about the presence of obesity and metabolic
syndrome in children and adolescents. However, there is no consensus regarding the diagnosis of
metabolic syndrome in children and adolescents. It is evident that each component of the syndrome
must be identified as early as possible in order to prevent definitive lesions. The question is how
to do this and which cut-offs must be adopted for this diagnosis. For a matter of convenience, the
definition chosen as the most appropriate is the one proposed by the IDF, with cut-offs fixed for
pressure, lipids and glycemia, and abdominal circumference points assessed by percentile. Although
on the one hand this definition could fail to include some children in the diagnosis of Metabolic
Syndrome, on the other hand, it would be of easier acceptance as it does not use multiple tables
to assess several anthropometric and metabolic criteria.
Introduction
We are presently going through a paradox in Brazil
expressed by a decrease in infantile malnutrition from
16% in 1974 to 4.6% in 2003 with a gradual increase in
obesity, which today occurs in 18% of boys and 15% of
girls, according to the Family Budget Research (POF 2002-
2003). It is widely known that obesity has been increasing
over time and Brazilian data on malnutrition shows that
it is decreasing significantly, whereas obesity has been
increasing in an opposite way. Nowadays, 18% of boys
and 15% of girls are obese[1].
The Bogalusa study, which assessed 66 children autopsies
from six years old on with known cardiovascular risk fac-
tors, observed that the total cholesterol level and the
blood pressure of these children were proportional to the
infiltration of foam cells and to the amount of lipids in
the arterial intimate layer. Lesions were gradual, evolving
from the simple presence of fatty stretch marks to lesions
of fibrous plaques and finally to severe lesions character-
ized by atherosclerotic plaques with fibrosis and necrosis,
which have already been observed in children [2].
Evidently, this leads to losing years of life. If the individ-
ual's BMI indicates they are overweight from 20 years old
on, this would result in losing one year of life in the long
term. If we consider the effect of presenting morbid obes-
ity since 20 years of age, this would result in losing 12
years of life in the long term. The later the development of
overweight or obesity, fewer are the years of life lost [3].
Therefore, we may infer that it is important for us to treat
obesity and metabolic syndrome since childhood.
Several large epidemiologic cohort studies (such as Fram-
ingham Offspring Study, Botnia Study, Kuopio Ischemic
Heart Disease Study, NHANES II Mortality Study, San
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Antonio Heart Study and DECODE Study) have docu-
mented that metabolic syndrome is associated with cardi-
ovascular outcomes in adults, such as infarction,
cerebrovascular disease and sudden death [4]. In recent
years, there has been a greater concern about the presence
of obesity and metabolic syndrome in children and ado-
lescents. It was demonstrated in 2004 that the prevalence
of metabolic syndrome increases as it evolves from a
lower tertile to a higher tertile of insulin resistance. This
has been observed in different ethnical groups (Cauca-
sians, Hispanics and Blacks), and in different obesity
degrees (moderately obese and severely obese individu-
als). It has also been demonstrated that there is a direct
association between insulin resistance tertiles and C-reac-
tive protein, and inverse association with adiponectin lev-
els [5].
Metabolic Syndrome Diagnosis in Children and 
Adolescents
There is no consensus regarding the diagnosis of meta-
bolic syndrome in children and adolescents. It is evident
that each component of the syndrome must be identified
as early as possible in order to prevent definitive lesions.
The question is how to do this and which cut-offs must be
adopted for this diagnosis.
The diagnosis of metabolic syndrome in children and
adolescents requires the assessment of the abdominal cir-
cumference (or BMI), pressure, lipoproteins and glyc-
emia. There is even controversy about how to measure the
abdominal circumference in adults; measure points differ.
Thus, there are proposals: one of them was published in
1999 by Freedman, which is one of the authors of the
Bogalusa study [6]. In this article, the authors have corre-
lated the 90th percentile of abdominal circumference with
increased levels of LDL cholesterol, glycemia, insulin and
diminished HDL levels. Limits were established and the
use of a chart for abdominal circumference was proposed
(over the 90th percentile, considered to be the maximum
normal limit).
By the other hand, Taylor proposed different values. He
compared abdominal circumference with abdominal fat
measured by densitometry [7]. The possible criticism is
that, depending on the age range, the number of children
analyzed was very low.
Some people claim that the metabolic syndrome in chil-
dren must be defined by BMI and not by the abdominal
circumference. An adjusted BMI curve according to gender
and age was proposed to the Brazilian population, elabo-
rated by the group of Prof. Carlos Monteiro from the Pub-
lic Health School of University of Sao Paulo (USP) [8].
Despite the existence of this curve even for the matter of
comparing studies, BMI curves adjusted by the North-
American CDC have been more widely used. The normal
BMI varies according to the child's age. Thus, it is impos-
sible to apply a BMI range of 18.5-24.9 to a 12 or 13-year-
old child. Overweight is defined from 85th percentile and
obesity from 95th percentile [9] (Charts are available at
http://www.cdc.gov).
Regarding blood pressure, tables must also be used. Addi-
tionally, the inflatable cuff width must be at least 40% of
the arm circumference and its length must be at least 80%
of the distance between the elbow and the acromion. In
practice, it is not necessary to constantly measure the dis-
tance, but one must certify that the sleeve occupies most
of the arm length circumference. It is recommended to
verify the blood pressure of all children from 3 years old
on and of children under 3 in case they have associated
risk factors [10]
(Charts are available at http://www.nhlbi.nih.gov/guide
lines/hypertension/child_tbl.htm).
Regarding lipoproteins, a recent document of the Ameri-
can Academy of Pediatrics establishes the percentiles of
total cholesterol, triglycerides, LDL and HDL for boys and
girls of several age ranges. Regarding lipoproteins, below
the 75th percentile is considered acceptable, correspond-
ing to total cholesterol below 170 mg/dL and LDL below
110 mg/dL. Between 75th and 95th percentile considered
borderline and elevated is over 95th percentile. Pharmaco-
logical treatment is indicated in the following cases: if risk
factors with LDL persistently over 190 mg/dL are not
Table 1: Proposals for rating the metabolic syndrome in children and adolescents
Cook et al. De Ferranti et al.W e i s s   et al.
3 or more among the 5 criteria below
Adiposity: abdominal circumference (AC) or BMI AC ≥ p 90th AC > p 75th BMI z score ≥ 2,0
Fasting glycemia or at OGTT (mg/dL) Fasting gly ≥ 110 Fasting gly ≥ 110 Glycemia at OGTT of 140-200
Blood pressure ≥ p 90th > p 90th > p 95th
HDL Cholesterol (mg/dL) ≤ 40 < 50 (girls) e < 45 (boys) < p 5th
Triglycerides (mg/dL) ≥ 110 ≥ 100 > p 95thDiabetology & Metabolic Syndrome 2009, 1:20 http://www.dmsjournal.com/content/1/1/20
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present; if there is any risk factor such as obesity, hyper-
tension or smoking and LDL over 160 mg/dL; and dia-
betic patients with LDL over 130 mg/dL [11].
Regarding fasting glucose levels, values considered for
children and for adults were the same.
Proposals of Definition of Metabolic Syndrome 
in Children and Adolescents
The first proposal of definition was published in 2003. It
was elaborated by assessing adolescents from 12 to 19
years old using modified criteria, based on the criteria of
NCEP/ATP-III, including abdominal circumference over
percentile 90, blood pressure over the limits established
by the National Blood Pressure Education Program, lipids
over the limits established by the National Cholesterol
Education Program for children, and glycemia over the
values for adults. The general prevalence found in this
population of 12-19 years old patients was 4.2%, and
when only obese patients over the percentile 95 were con-
sidered, the prevalence was 28.7% [12].
The second proposal of definition is very similar to the
previous one, but the cut offs were inferior regarding
abdominal circumference and lipid profile. Thus, preva-
lence is higher (when considering patients with BMI per-
centile adjusted over the percentile 85, it was 31%) [13].
The third proposal chose BMI to serve as a base, justifying
that it would be less dependent on ethnical variations - we
are aware that abdominal circumference may vary accord-
ing to the race. The prevalence in moderately obese
patients (considering those who had Z of 2 and 2.5) was
38.7%, and in severe obese patients (with Z over 2.5 of
pattern deviations), it was 49.7% [14] (Table 1).
Finally, the definition we believe is most appropriate and
which was added to this SBD publication is the one pro-
posed by the IDF. It divided children into age groups.
There was not a well defined proposal for children under
6 years of age, due to the lack of data. Differently from the
criteria presented above, in this proposal, for a matter of
convenience, the cut-offs were fixed for pressure, lipids
and glycemia, and abdominal circumference points were
assessed by percentile. In children aged 6-10, the cut-offs
of metabolic and blood pressure variables were not well
defined, assessing simply adiposity (considering abdomi-
nal circumference over the 90th percentile). The same cri-
teria would be used for children aged 10-16; regarding
glycemic metabolism, fasting glycemia ≥100 mg/dL, trig-
lycerides ≥150 mg/dL, HDL cholesterol below 40 mg/dL
or using a hypolipemiant drug, and blood pressure limits
≥130 or ≥85 mmHg or using a antihypertensive drug. If
the patient had altered abdominal circumference and two
more factors, the metabolic syndrome diagnosis would be
established. The difference is that, for adolescents over 16
years of age, there is a differentiation between HDL ≤40
for men and ≤50 for women (Table 2) [15].
Thus, discussions and doubts exist about which criterion
to use. Evidently, the IDF criterion, though more conven-
ient, could fail to include some children in the diagnosis
of Metabolic Syndrome. On the other hand, it would be
of easier acceptance as it does not use multiple tables to
assess several anthropometric and metabolic criteria.
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